Streamlining Screening to Treatment: The Hepatitis C Cascade of Care at Kaiser Permanente Mid-Atlantic States

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M Cabell JonasBernadette C Loftus

Abstract

Hepatitis C virus (HCV) screening is recommended for patients at risk and/or born during 1945-1965, but screening gaps persist. This new program screens target populations and enhances care linkage for chronically HCV-infected patients. Kaiser Permanente Mid-Atlantic States created a comprehensive HCV screening pathway, supported by a HCV care coordinator. The testing pathway includes HCV antibody (Ab), automatic HCV RNA for Ab-positive patients, coinfection and liver health tests, vibration-controlled transient elastography (VCTE), and a physician referral. A total of 11 200 patients were screened; 3.25% were HCV Ab positive, and 100% of Ab-positive patients received HCV RNA testing. Of HCV Ab-positive patients, 75.9% had chronic HCV, of which 80.8% underwent VCTE. HCV diagnosis was communicated to 94% of patients, and 70.9% had HCV documented in the electronic health record. The pathway shows promise in closing gaps, including improving HCV RNA testing, communicating diagnoses, and assessing liver fibrosis. Improved testing and linkage could increase curative treatment access.

References

Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
May 17, 2006·Annals of Internal Medicine·Gregory L ArmstrongMiriam J Alter
Jun 15, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anaïs Vallet-PichardStanislas Pol
Nov 10, 2009·Journal of the American Board of Family Medicine : JABFM·Robert R LeverenceUNKNOWN PRIME Net Consortium
Jan 11, 2011·AIDS Patient Care and STDs·Michael HorbergMichael Johnson
Jan 22, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stella M MartínezXavier Forns
Jun 24, 2011·The New England Journal of Medicine·Ira M JacobsonUNKNOWN ADVANCE Study Team
Jan 4, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maxine M DennistonRuth B Jiles
Feb 2, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael A HorbergCharles P Quesenberry
Sep 20, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne C MoormanUNKNOWN Chronic Hepatitis Cohort Study Investigators
Apr 24, 2013·The New England Journal of Medicine·Ira M JacobsonUNKNOWN FUSION Study
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
May 17, 2013·The New England Journal of Medicine·Scott D HolmbergMaxine M Denniston
Dec 29, 2013·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Seung Woo ChaYoung Hwan Kim
Jan 24, 2014·Current Gastroenterology Reports·Alan Bonder, Nezam Afdhal
Feb 4, 2014·The American Journal of Medicine·Benjamin P LinasMichael Horberg
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators
Feb 24, 2015·JAMA : the Journal of the American Medical Association·Camilla S Graham
Jun 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·UNKNOWN AASLD/IDSA HCV Guidance Panel

❮ Previous
Next ❯

Citations

Apr 21, 2017·American Journal of Public Health·Fabienne Laraque, Jay K Varma
Feb 17, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erik S AndersonDouglas A E White
Jun 15, 2018·Public Health Reports·Miranda S MooreAnn Winters
Aug 25, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Sofia R BartlettNaveed Z Janjua
Jun 22, 2019·Canadian Journal of Public Health = Revue Canadienne De Santé Publique·Conar R O'NeilStephen Shafran
Feb 6, 2020·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Elena M WojcikCarmen N Burrell
Sep 13, 2019·Journal of Community Health·David M HacheyNicki L Aubuchon-Endsley
Jul 29, 2017·Open Forum Infectious Diseases·Mariana CastrejónJeffrey D Klausner
Apr 6, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mamta K JainAmit G Singal
Dec 14, 2018·Current Treatment Options in Infectious Diseases·Autumn ZuckermanCody A Chastain
Jan 14, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Carla Rodriguez-WatsonBernadette Loftus
Oct 23, 2020·Pharmacoepidemiology and Drug Safety·Taruja KarmarkarCarla V Rodriguez
Jan 19, 2021·Journal of General and Family Medicine·Takashi WatariYu Amano
Jan 30, 2021·Journal of Translational Internal Medicine·Chantal GomesRobert J Wong
Sep 9, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·James HaridyTimothy Fazio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Claudia HawkinsRobert L Murphy
JAMA : the Journal of the American Medical Association
Camilla S Graham
© 2022 Meta ULC. All rights reserved